Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial

BACKGROUND: After the SMART trial evaluating the safety of salmeterol (long-acting beta-2-agonist (LABA)) in asthma patients, regulatory actions were taken to promote a guideline-adherent prescribing of LABA only to patients receiving inhaled corticosteroids (ICS). We aim to analyse LABA- and ICS-re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Pulm Med
Main Authors: Rottenkolber, Marietta, Fischer, Rainald, Ibáñez, Luisa, Fortuny, Joan, Reynolds, Robert, Amelio, Justyna, Gerlach, Roman, Tauscher, Martin, Thürmann, Petra, Hasford, Joerg, Schmiedl, Sven
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4428117/
https://ncbi.nlm.nih.gov/pubmed/25943421
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-015-0051-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados